Search results

Sixteen people walk into a bar... Sounds like an old joke, right? Except it isn't funny. Florida allowed some bars to open on June 5. One day later the 16 met in a packed Jacksonville Beach bar. All 16 came down with Covid-19. Perhaps someone ought to rethink that decision.

When we share our thoughts on science as well as our research efforts, the collective good is not well-served if we're speaking only to those who already share our perspective. And specifically, If we cannot convince our own colleagues that there's a serious and growing threat to their ability to continue to treat bacterial infections, then we cannot expect governments to believe us either. That has to change.

The BBC reports that the first life-saving drug for COVID-19 has been identified. While that is strictly true, without more context and numbers the impact of dexamethasone is obscured. Is this drug just click-bait material or actually a "major breakthrough"?

This past weekend at West Point, President Trump had trouble drinking a glass of water and he displayed an unsteady gait when descending a ramp. It is possible these problems indicate some type of neuropathy. And while it's unlikely, one potential cause is hydroxychloroquine.

Perhaps someday a ballad will be written about the tragic tale of hydroxychloroquine (HCQ) and its ugly cousin chloroquine (CQ). HCQ, a potential (and controversial) therapy for COVID-19 at one time, is no more. The FDA revoked the emergency authorization of both HCQ and CQ. This was an example of how NOT to develop a drug. A lesson learned -- or not.

Some 54 scientists have resigned or been fired as a result of an ongoing investigation by the National Institutes of Health. At issue is the failure of NIH grantees to disclose financial ties to foreign governments. In 93% of those cases, the hidden funding came from a Chinese institution.

Remember the wisdom of the not-so-distant past? Leaving delivered boxes outside for 24 hours, then donning gloves to wipe them down before carefully opening the cartons? It’s time to shed a bit of scientific light on what we know now. 

The pandemic isn't making the world any brighter. Insecticides are being sold online to treat or prevent COVID-19 -- and people are buying them. Speaking of pesticides, you probably had a healthy dose of one this morning and it's more toxic than DDT. Drink up!

Peer review, especially peer review of chemical safety/risk assessments, is under assault. Is something inherently wrong with the process of this area of peer review?

Most drug and vaccine candidates fail. However, the success rate varies wildly depending on the therapeutic area. The probability that at least one coronavirus vaccine will win FDA approval is quite high, though that does not mean it will work well.

The more recent cases of COVID-19 seem to be coming from homes and family contacts, rather than from strangers. And there, with the "opening up" of social mobility, is an increasing interest in the spread and dispersion of airborne COVID-19 particles. There are lessons to be learned from atmospheric science, especially when it pertains to the dispersion of small particles.

A walk on the thoughtful “wild side” of why old-school epidemiology has over-promised and under-delivered, discovering that population density is more than how tightly we are packed, an alternative hypothesis for how sleep refreshes our bodies and spirits, and an update on a maligned energy source, fusion.  

Should Facebook be in the business of "debunking" news and scientific data when events are rapidly changing? What's true today may be declared false tomorrow, only to be declared true again a week later. Furthermore, does Facebook have the expertise to do so?

We have rightfully focused our nation’s health care attention on how best to manage the potentially deadly COVID-19 virus through treatment and/or prevention. The next few months will be telling, but we can now begin to focus on the future — one that may include new health care challenges given that fewer patients have been seeking preventative care or measures during the pandemic. ACSH friend Dr. Robert Popovian (pictured), VP of Pfizer's U.S. Government Relations, and colleague Dave Hering, regional president, North America for Pfizer Vaccines, discuss the challenges ahead.

"Recency bias" states that more recent memories come to mind more quickly. But specific ideas and objects that have “stood the test of time” can overcome recency bias. How do we take longevity into account when making judgments? Are old conserved ideas better than the novel? In the attention economy novel wins, but what about in our day-to-day lives?

Are bald men more likely to get severe COVID-19? There are more than 30,000 news stories about this, almost all of which without question, accept the findings of a flawed epidemiological study from Spain. Is this a valid conclusion? Let's ask a biostatistician.

Faced with a life-changing decision and a great deal of uncertainty, do patients prefer to decide for themselves after being given all the facts? Or do they prefer a nudge in “the right direction” by their physician?

Making life or death decisions has been brought into sharp relief by the COVID-19 pandemic. For the estimated 500,000 people on dialysis in the U.S., that is a bridge already crossed. Having chosen a life requiring continuous life support, do any of them have second thoughts?

Discredited journalist and conspiracy theorist Paul Thacker, who became infamous for spreading disinformation about GMOs and biotech scientists, is back. This time, he's ranting about 5G. But it seems he could only get his most recent work published in a foreign language with the help of a collaborator, Dutch journalist Jannes van Roermund.

As our population ages and our medical care improves, we have increasing numbers of frail patients. The frail require gentler, longer, and frequently more expensive care. A new study looks at these outcomes.

From a public health perspective, what's the biggest preventable cause of cancer? Pesticides? Poor diet? Pollution? UV light? No, no, no, and nope. It's tobacco, by far. Obesity and infectious diseases are #2 and #3.

A new study looks at how the American diet has changed after 17 years of cajoling. It's time to begin thinking outside the box -- pizza or otherwise.

Yes, 65. Here are the articles we have published on the opioid crisis written by ACSH's Dr. Josh Bloom. Grouped and categorized, we're also providing his research to date as a reference guide for media.

The Drug Enforcement Administration, having virtually eliminated the diversion of prescription pain relievers into the underground market for nonmedical users, appears to be setting its sights on regulating the medical management of pain, a mission not suited for law enforcement.

Vaxart, a biopharmaceutical company, is working on a vaccine for the dreaded norovirus. The company just released its Phase Ib results. Did it work? Our lips are sealed. But here are some thoughts on its chances for success.